{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:33:01Z","timestamp":1785684781397,"version":"3.56.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3450,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/modpathol.2013.34","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T08:43:01Z","timestamp":1363336981000},"page":"1132-1143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Nelson G","family":"Ord\u00f3\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.34_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000478-198904000-00003","article-title":"The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma","volume":"13","author":"Ord\u00f3\u00f1ez","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0046-8177(90)90036-5","article-title":"Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases","volume":"21","author":"Wick","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0046-8177(93)90080-Z","article-title":"Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma","volume":"24","author":"Brown","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2559.2000.00770.x","article-title":"HBME-1, MOC-31, WT1 and calretinin: as assessment of recently described markers for mesothelioma and adenocarcinoma","volume":"36","author":"Oates","year":"2000","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000478-200101000-00004","article-title":"Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis","volume":"25","author":"Carella","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/hupa.2001.24329","article-title":"Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma","volume":"32","author":"Comin","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2559.1995.tb01527.x","article-title":"A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm\u2013Horsfall protein and thrombomodulin","volume":"27","author":"Attanoos","year":"1995","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2559.2002.01527.x","article-title":"The value of \u2018mesothelium-associated\u2019 antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas","volume":"41","author":"Osborn","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.humpath.2003.11.013","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study","volume":"35","author":"Ord\u00f3\u00f1ez","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2559.2002.14044.x","article-title":"Foamy cell mesothelioma","volume":"41","author":"Cavazza","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.humpath.2005.02.014","article-title":"Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/121.1.43","article-title":"Thoracic manifestations of renal cell carcinoma","volume":"121","author":"Latour","year":"1976","journal-title":"Radiology"},{"key":"10.1038\/modpathol.2013.34_bib14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/thx.42.11.901","article-title":"Metastatic renal cell carcinoma mimicking pleural mesothelioma","volume":"42","author":"Taylor","year":"1987","journal-title":"Thorax"},{"key":"10.1038\/modpathol.2013.34_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/003655999750016186","article-title":"Metastatic renal cell carcinoma mimicking pleural mesothelioma","volume":"33","author":"Azuma","year":"1999","journal-title":"Scand J Urol Nephrol"},{"key":"10.1038\/modpathol.2013.34_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","article-title":"\u2018Pseudomesotheliomatous\u2019 carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-1843.2005.00652.x","article-title":"Metastatic renal cell carcinoma presenting as multiple pleural tumours","volume":"10","author":"Ohnishi","year":"2005","journal-title":"Respirology"},{"key":"10.1038\/modpathol.2013.34_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.2910610503","article-title":"International renal-cell cancer study. IV. Occupation","volume":"61","author":"Mandel","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.34_bib19","first-page":"37","article-title":"Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies","volume":"11","author":"Sali","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1038\/modpathol.2013.34_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0007-0971(76)90039-5","article-title":"Distant visceral metastases in pleural mesothelioma","volume":"70","author":"Roberts","year":"1976","journal-title":"Br J Dis Chest"},{"key":"10.1038\/modpathol.2013.34_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2010-0478-RAR.1","article-title":"Immunohistochemical diagnosis of renal neoplasms","volume":"135","author":"Truong","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2013.34_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1523\/JNEUROSCI.14-03-01395.1994","article-title":"Roles of Pax-genes in developing and adult brain as suggested by expression patterns","volume":"14","author":"Stoykova","year":"1994","journal-title":"J Neurosci"},{"key":"10.1038\/modpathol.2013.34_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"10.1038\/modpathol.2013.34_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study","volume":"22","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1600-0560.2010.01564.x","article-title":"PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases","volume":"37","author":"Fujiwara","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1038\/modpathol.2013.34_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PAS.0b013e3182064d11","article-title":"PAX2(\u2212)\/PAX8(\u2212)\/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/PAS.0b013e3182152629","article-title":"Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases","volume":"35","author":"Sangoi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAP.0b013e318253465d","article-title":"Value of PAX 8 immunostaining in tumor diagnosis: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2013.34_bib32","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1242\/dev.121.12.4057","article-title":"Pax-2 controls multiple steps of urogenital development","volume":"121","author":"Torres","year":"1995","journal-title":"Development"},{"key":"10.1038\/modpathol.2013.34_bib33","first-page":"463","article-title":"Pax2 in development and renal disease","volume":"43","author":"Dressler","year":"1999","journal-title":"Int J Dev Biol"},{"key":"10.1038\/modpathol.2013.34_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/hupa.2001.22753","article-title":"Pax-2 expression in adult renal tumors","volume":"32","author":"Daniel","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/PAS.0b013e318181b828","article-title":"Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms","volume":"33","author":"Gupta","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAI.0b013e3181d712ef","article-title":"PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study","volume":"18","author":"Zhai","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/modpathol.3800320","article-title":"Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study","volume":"18","author":"Mazal","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1309\/9KWEA4W9Y94D1AEE","article-title":"Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma","volume":"127","author":"Memeo","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2013.34_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/dc.20839","article-title":"Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration","volume":"36","author":"Wasco","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2013.34_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1309\/AJCPM7DW0XFHDHNY","article-title":"PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin","volume":"131","author":"Ozcan","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2013.34_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2559.2011.03753.x","article-title":"Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics","volume":"58","author":"Carvalho","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PAI.0b013e3181e78ff8","article-title":"The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features","volume":"18","author":"Sharma","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib43","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/PAS.0b013e318176dba7","article-title":"The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker","volume":"32","author":"Gokden","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1789.2010.01109.x","article-title":"Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma","volume":"30","author":"Rivera","year":"2010","journal-title":"Neuropathology"},{"key":"10.1038\/modpathol.2013.34_bib45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary M\u00fcllerian system origin?","volume":"20","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAP.0b013e318271a382","article-title":"Value of PAX2 Immunostaining in tumor diagnosis: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2013.34_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PAP.0b013e31823e472e","article-title":"Napsin A expression in lung and kidney neoplasia: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2013.34_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1679\/aohc.65.359","article-title":"Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules","volume":"65","author":"Mori","year":"2002","journal-title":"Arch Histol Cytol"},{"key":"10.1038\/modpathol.2013.34_bib49","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2009.06.014","article-title":"Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma","volume":"41","author":"Bishop","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/cncy.20108","article-title":"The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas","volume":"118","author":"Stoll","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2013.34_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAI.0b013e318205b059","article-title":"Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung","volume":"19","author":"Ye","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-5002(03)00194-6","article-title":"Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma","volume":"41","author":"Hirano","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2013.34_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/dc.20667","article-title":"Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions","volume":"35","author":"Dejmek","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2013.34_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","article-title":"Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"55","author":"Amatya","year":"2009","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.bi.64.070195.002111","article-title":"Human carbonic anhydrases and carbonic anhydrase deficiencies","volume":"64","author":"Sly","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/modpathol.2013.34_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2013.34_bib58","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.34_bib59","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao","year":"1997","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.34_bib60","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.ejca.2010.07.020","article-title":"Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment","volume":"46","author":"Tostain","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2013.34_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1464-410X.2005.05615.x","article-title":"Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma","volume":"96","author":"Leppert","year":"2005","journal-title":"BJU Int"},{"key":"10.1038\/modpathol.2013.34_bib62","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","article-title":"Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma","volume":"25","author":"Leibovich","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.34_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181570343","article-title":"Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies","volume":"32","author":"Al-Ahmadie","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib64","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","article-title":"Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade","volume":"134","author":"Genega","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1038\/modpathol.2013.34_bib65","first-page":"182A","article-title":"Comparison of putative renal cell carcinoma (RCC) immunohistochemical (IHC) markers in primary adrenal cortical lesions (ACL) and metastatic RCC: a tissue microarray study of 246 cases","volume":"22","author":"McKenney","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib66","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.humpath.2009.05.006","article-title":"Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis","volume":"40","author":"Osunkoya","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/PAI.0b013e3181ddf7b9","article-title":"Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers","volume":"18","author":"Lapinski","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PAI.0b013e3181dd35d2","article-title":"Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma","volume":"18","author":"Prayson","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00428-011-1178-7","article-title":"Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung","volume":"460","author":"Ramsey","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.34_bib70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.34_bib71","first-page":"1802","article-title":"Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas","volume":"49","author":"Yoshida","year":"1989","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.34_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000478-200002000-00006","article-title":"Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms","volume":"24","author":"Avery","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2559.2004.01962.x","article-title":"The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases","volume":"45","author":"Pan","year":"2004","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib74","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/00000478-200112000-00003","article-title":"Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'renal cell carcinoma marker'","volume":"25","author":"McGregor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib75","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5858\/2006-130-823-EORCCM","article-title":"Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma","volume":"130","author":"Butnor","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2013.34_bib76","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.pai.0000213144.70148.8e","article-title":"Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic implications","volume":"15","author":"Bakshi","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib77","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2559.2007.02900.x","article-title":"Profiling and classification tree applied to renal epithelial tumours","volume":"52","author":"Allory","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.pai.0000146525.72531.19","article-title":"Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique","volume":"13","author":"Pan","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2559.2008.03003.x","article-title":"Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma","volume":"52","author":"Ingold","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00129039-200306000-00003","article-title":"Renal cell carcinoma antigen is expressed by yolk sac tumors and yolk sac elements of embryonal carcinomas","volume":"11","author":"Yan","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/283583a0","article-title":"A monoclonal antibody to human acute lymphoblastic leukaemia antigen","volume":"283","author":"Ritz","year":"1980","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.34_bib82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2559.2001.01215.x","article-title":"CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms","volume":"39","author":"McCluggage","year":"2001","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)62528-X","article-title":"cDNA arrays and immunohistochemistry identification of CD10\/CALLA expression in hepatocellular carcinoma","volume":"159","author":"Xiao","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.34_bib84","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00129039-200212000-00008","article-title":"Immunohistochemical profile of common epithelial neoplasms arising in the kidney","volume":"10","author":"Kim","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2013.34_bib85","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2559.2004.01982.x","article-title":"CD10 is a diagnostic and prognostic marker in renal malignancies","volume":"45","author":"Langner","year":"2004","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib86","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/modpathol.3800236","article-title":"CD10 is expressed in a subset of chromophobe renal cell carcinomas","volume":"17","author":"Martignoni","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.pas.0000180443.94645.50","article-title":"Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution","volume":"30","author":"Paner","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib88","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/2007-131-1290-IAOCRC","article-title":"Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis","volume":"131","author":"Liu","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2013.34_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.34_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.2005.028589","article-title":"Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura","volume":"59","author":"Soini","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2013.34_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib92","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2559.2005.02127.x","article-title":"Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours","volume":"46","author":"Soini","year":"2005","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib93","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","article-title":"Calretinin: a novel immunocytochemical marker for mesothelioma","volume":"20","author":"Doglioni","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib94","first-page":"929","article-title":"Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma","volume":"11","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib95","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","article-title":"Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib96","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/modpathol.3880386","article-title":"Parvalbumin is constantly expressed in chromophobe renal carcinoma","volume":"14","author":"Martignoni","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib97","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","article-title":"Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples","volume":"34","author":"Lugli","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib99","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/00000478-199810000-00006","article-title":"Value of cytokeratin 5\/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma","volume":"22","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004347-200104000-00007","article-title":"The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary","volume":"20","author":"Nolan","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2013.34_bib101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.pas.0000163362.78475.63","article-title":"Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors","volume":"29","author":"Skinnider","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib102","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00000478-200004000-00016","article-title":"Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma","volume":"24","author":"Ord\u00f3\u00f1ez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/dc.20747","article-title":"Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5\/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions","volume":"36","author":"Pu","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2013.34_bib104","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/00000478-200110000-00010","article-title":"Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison","volume":"25","author":"Muir","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/dc.21375","article-title":"Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology","volume":"39","author":"Chute","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/modpathol.2013.34_bib106","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","article-title":"Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib107","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib108","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib109","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2559.2005.02279.x","article-title":"The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies","volume":"48","author":"Galloway","year":"2006","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.34_bib110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib111","first-page":"827","article-title":"Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma","volume":"141","author":"Collins","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.34_bib112","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/00000478-199712000-00002","article-title":"Value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies","volume":"21","author":"Ord\u00f3\u00f1ez","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib113","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199712000-00003","article-title":"The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval","volume":"21","author":"Riera","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.34_bib114","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jcp.50.10.859","article-title":"HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura","volume":"50","author":"Kennedy","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2013.34_bib115","unstructured":"Husain AN, Colby T, Ord\u00f3\u00f1ez N et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2012, (e-pub ahead of print)."},{"key":"10.1038\/modpathol.2013.34_bib116","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humpath.2005.08.008","article-title":"Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.34_bib117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.34_bib118","doi-asserted-by":"crossref","unstructured":"Ord\u00f3\u00f1ez NG . Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol 2012, (e-pub ahead of print).","DOI":"10.1038\/modpathol.2012.200"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201334","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222021068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222021068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:56:12Z","timestamp":1760230572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222021068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0893395222021068"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.34","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.34","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}